268 related articles for article (PubMed ID: 10433852)
61. Downregulation of calpastatin in rat heart after brief ischemia and reperfusion.
Sorimachi Y; Harada K; Saido TC; Ono T; Kawashima S; Yoshida K
J Biochem; 1997 Oct; 122(4):743-8. PubMed ID: 9399577
[TBL] [Abstract][Full Text] [Related]
62. Defining a link between gap junction communication, proteolysis, and cataract formation.
Baruch A; Greenbaum D; Levy ET; Nielsen PA; Gilula NB; Kumar NM; Bogyo M
J Biol Chem; 2001 Aug; 276(31):28999-9006. PubMed ID: 11395508
[TBL] [Abstract][Full Text] [Related]
63. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells.
Vaisid T; Barnoy S; Kosower NS
Neuroscience; 2008 Oct; 156(4):921-31. PubMed ID: 18786620
[TBL] [Abstract][Full Text] [Related]
64. Interaction between catalytically inactive calpain and calpastatin. Evidence for its occurrence in stimulated cells.
Averna M; Stifanese R; De Tullio R; Defranchi E; Salamino F; Melloni E; Pontremoli S
FEBS J; 2006 Apr; 273(8):1660-8. PubMed ID: 16623703
[TBL] [Abstract][Full Text] [Related]
65. Dysregulation of the calpain-calpastatin system plays a role in the development of cerulein-induced acute pancreatitis in the rat.
Weber H; Jonas L; Hühns S; Schuff-Werner P
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G932-41. PubMed ID: 15132950
[TBL] [Abstract][Full Text] [Related]
66. Comparison of various calpain inhibitors in reduction of light scattering, protein precipitation and nuclear cataract in vitro.
Mathur P; Gupta SK; Wegener AR; Breipohl W; Ahrend MH; Sharma YD; Gupta YK; Vajpayee RB
Curr Eye Res; 2000 Dec; 21(6):926-33. PubMed ID: 11262616
[TBL] [Abstract][Full Text] [Related]
67. Activation of calpain in lens: a review and proposed mechanism.
Azuma M; Fukiage C; David LL; Shearer TR
Exp Eye Res; 1997 Apr; 64(4):529-38. PubMed ID: 9227270
[TBL] [Abstract][Full Text] [Related]
68. Structure and physiology of calpain, an enigmatic protease.
Ono Y; Sorimachi H; Suzuki K
Biochem Biophys Res Commun; 1998 Apr; 245(2):289-94. PubMed ID: 9571143
[TBL] [Abstract][Full Text] [Related]
69. Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-l-cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes.
Dnyanmote AV; Sawant SP; Lock EA; Latendresse JR; Warbritton AA; Mehendale HM
Toxicol Appl Pharmacol; 2006 Sep; 215(2):146-57. PubMed ID: 16546232
[TBL] [Abstract][Full Text] [Related]
70. Expression and immunolocalization of the calpain-calpastatin system during parthenogenetic activation and fertilization in the rat egg.
Haim K; Ben-Aharon I; Shalgi R
Reproduction; 2006 Jan; 131(1):35-43. PubMed ID: 16388007
[TBL] [Abstract][Full Text] [Related]
71. The effect of acetyl-L-carnitine on lenticular calpain activity in prevention of selenite-induced cataractogenesis.
Elanchezhian R; Sakthivel M; Geraldine P; Thomas PA
Exp Eye Res; 2009 May; 88(5):938-44. PubMed ID: 19150348
[TBL] [Abstract][Full Text] [Related]
72. Comparison of calpain and calpastatin activities in skeletal muscle of broiler and layer chickens.
Johari S; Maeda Y; Okamoto S; Hashiguchi T
Br Poult Sci; 1993 Sep; 34(4):819-24. PubMed ID: 8242418
[TBL] [Abstract][Full Text] [Related]
73. The calpastatin-derived calpain inhibitor CP1B reduces mRNA expression of matrix metalloproteinase-2 and -9 and invasion by leukemic THP-1 cells.
Popp O; Heidinger M; Ruiz-Heinrich L; Ries C; Jochum M; Gil-Parrado S
Biol Chem; 2003 Jun; 384(6):951-8. PubMed ID: 12887063
[TBL] [Abstract][Full Text] [Related]
74. 3-[2-[4-(3-Chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism: role of the cross-talk between calpain and caspase-3 through calpastatin.
Han F; Shirasaki Y; Fukunaga K
J Pharmacol Exp Ther; 2006 May; 317(2):529-36. PubMed ID: 16467455
[TBL] [Abstract][Full Text] [Related]
75. Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis.
Galvez AS; Diwan A; Odley AM; Hahn HS; Osinska H; Melendez JG; Robbins J; Lynch RA; Marreez Y; Dorn GW
Circ Res; 2007 Apr; 100(7):1071-8. PubMed ID: 17332428
[TBL] [Abstract][Full Text] [Related]
76. Possible involvement of calpain activation in pathogenesis of chronic heart failure after acute myocardial infarction.
Takahashi M; Tanonaka K; Yoshida H; Koshimizu M; Daicho T; Oikawa R; Takeo S
J Cardiovasc Pharmacol; 2006 Mar; 47(3):413-21. PubMed ID: 16633084
[TBL] [Abstract][Full Text] [Related]
77. Multiple forms of calpastatin in pig brain.
Takano E; Hamakubo T; Kawatani Y; Ueda M; Kannagi R; Murachi T
Biochem Int; 1989 Sep; 19(3):633-43. PubMed ID: 2554916
[TBL] [Abstract][Full Text] [Related]
78. Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors.
Barnoy S; Glaser T; Kosower NS
Biochim Biophys Acta; 1997 Sep; 1358(2):181-8. PubMed ID: 9332454
[TBL] [Abstract][Full Text] [Related]
79. Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord.
Li J; Grynspan F; Berman S; Nixon R; Bursztajn S
J Neurobiol; 1996 Jun; 30(2):177-91. PubMed ID: 8738748
[TBL] [Abstract][Full Text] [Related]
80. Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3.
Wei W; Fareed MU; Evenson A; Menconi MJ; Yang H; Petkova V; Hasselgren PO
Am J Physiol Regul Integr Comp Physiol; 2005 Mar; 288(3):R580-90. PubMed ID: 15563579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
